{
  "pmcid": "4033571",
  "config": {
    "model": "gpt",
    "strategy": "zero-shot"
  },
  "usage": {
    "input": 15358,
    "output": 837
  },
  "raw_text": "{\"extractions\":[{\"outcome\":\"Overall seizure median percent improvement\",\"intervention\":\"Extended-release oxcarbazepine 2400 mg\",\"comparator\":\"Control\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":111,\"comparator_events\":null,\"comparator_group_size\":117,\"intervention_mean\":-42.9,\"intervention_standard_deviation\":null,\"comparator_mean\":-28.7,\"comparator_standard_deviation\":null},{\"outcome\":\"Adverse effects\",\"intervention\":\"Extended-release oxcarbazepine 1200 mg\",\"comparator\":\"Control\",\"outcome_type\":\"binary\",\"intervention_events\":69,\"intervention_group_size\":122,\"comparator_events\":67,\"comparator_group_size\":121,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Overall seizure median percent reduction\",\"intervention\":\"Extended-release oxcarbazepine 1200 mg\",\"comparator\":\"Control\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":109,\"comparator_events\":null,\"comparator_group_size\":117,\"intervention_mean\":-38.2,\"intervention_standard_deviation\":null,\"comparator_mean\":-28.7,\"comparator_standard_deviation\":null},{\"outcome\":\"Seizure median percent improvement in North America\",\"intervention\":\"Extended-release oxcarbazepine 1200 mg\",\"comparator\":\"Control\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":40,\"comparator_events\":null,\"comparator_group_size\":41,\"intervention_mean\":-34.5,\"intervention_standard_deviation\":null,\"comparator_mean\":-13.3,\"comparator_standard_deviation\":null},{\"outcome\":\"Seizure median percent improvement in North America\",\"intervention\":\"Extended-release oxcarbazepine 2400 mg\",\"comparator\":\"Control\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":35,\"comparator_events\":null,\"comparator_group_size\":41,\"intervention_mean\":-52.7,\"intervention_standard_deviation\":null,\"comparator_mean\":-13.3,\"comparator_standard_deviation\":null},{\"outcome\":\"Adverse effects\",\"intervention\":\"Extended-release oxcarbazepine 2400 mg\",\"comparator\":\"Control\",\"outcome_type\":\"binary\",\"intervention_events\":85,\"intervention_group_size\":123,\"comparator_events\":67,\"comparator_group_size\":121,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null}]}",
  "extraction": [
    {
      "outcome": "Overall seizure median percent improvement",
      "intervention": "Extended-release oxcarbazepine 2400 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 111,
      "comparator_events": null,
      "comparator_group_size": 117,
      "intervention_mean": -42.9,
      "intervention_standard_deviation": null,
      "comparator_mean": -28.7,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Adverse effects",
      "intervention": "Extended-release oxcarbazepine 1200 mg",
      "comparator": "Control",
      "outcome_type": "binary",
      "intervention_events": 69,
      "intervention_group_size": 122,
      "comparator_events": 67,
      "comparator_group_size": 121,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Overall seizure median percent reduction",
      "intervention": "Extended-release oxcarbazepine 1200 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 109,
      "comparator_events": null,
      "comparator_group_size": 117,
      "intervention_mean": -38.2,
      "intervention_standard_deviation": null,
      "comparator_mean": -28.7,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Seizure median percent improvement in North America",
      "intervention": "Extended-release oxcarbazepine 1200 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 40,
      "comparator_events": null,
      "comparator_group_size": 41,
      "intervention_mean": -34.5,
      "intervention_standard_deviation": null,
      "comparator_mean": -13.3,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Seizure median percent improvement in North America",
      "intervention": "Extended-release oxcarbazepine 2400 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 35,
      "comparator_events": null,
      "comparator_group_size": 41,
      "intervention_mean": -52.7,
      "intervention_standard_deviation": null,
      "comparator_mean": -13.3,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Adverse effects",
      "intervention": "Extended-release oxcarbazepine 2400 mg",
      "comparator": "Control",
      "outcome_type": "binary",
      "intervention_events": 85,
      "intervention_group_size": 123,
      "comparator_events": 67,
      "comparator_group_size": 121,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    }
  ]
}